Diffusion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease.

Diffusion-weighted magnetic resonance imaging Dura mater graft-associated Creutzfeldt-Jakob disease Non-plaque-type Plaque-type Thalamus

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Nov 2020
Historique:
received: 29 06 2020
revised: 08 08 2020
accepted: 11 08 2020
pubmed: 22 8 2020
medline: 15 5 2021
entrez: 22 8 2020
Statut: ppublish

Résumé

To elucidate the extension patterns of the hyperintense areas on diffusion-weighted magnetic resonance imaging (DW-MRI) in patients with dura mater graft-associated Creutzfeldt-Jakob disease (dCJD). We collected the DW-MRI of dCJD cases identified by the CJD Surveillance Committee in Japan, between April 1999 and February 2018. The dCJD cases were classified into non-plaque and plaque-types. The relationship among the abnormal signals, the pathological classification, and the sites of grafting were analyzed. We collected DW-MRI of 11 patients with dCJD, all of whom were methionine homozygous at codon 129 of the prion protein gene. The age at onset was 41 (26-76) [median (range)] years, the age at dural grafting was 19 (10-53) years, and the incubation period was 22 (16-29) years. Eight dCJD cases were classified as non-plaque-type and three cases were plaque-type. Five of the non-plaque-type cases and all the plaque-type cases were pathologically confirmed. Brain DW-MRI was performed 3 (1-22) months after the onset. Most of the non-plaque-type cases showed brighter hyperintensity in the cerebral cortex and basal ganglia on the side of dural grafting. Subsequent DW-MRI showed widespread hyperintense lesions in the brain. Regarding the plaque-type cases, initial scans showed hyperintensity in the basal ganglia and the thalamus in one patient. Another patient's lesion was confined to the basal ganglia. The third patient showed no abnormalities seven months post-onset; however, serial images showed a hyperintensity confined to the thalamus. Non-plaque and plaque-types demonstrated different patterns of propagation of distinct prion strains.

Identifiants

pubmed: 32823134
pii: S0022-510X(20)30431-7
doi: 10.1016/j.jns.2020.117094
pii:
doi:

Substances chimiques

Prions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117094

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Kenji Sakai (K)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8604, Japan.

Tsuyoshi Hamaguchi (T)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8604, Japan.

Nobuo Sanjo (N)

Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.

Hiroyuki Murai (H)

Department of Neurology, School of Medicine, International University of Health and Welfare, 4-3 Kozunomori, Narita 286-8686, Japan.

Yasushi Iwasaki (Y)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute 480-1195, Japan.

Tadanori Hamano (T)

Second Department of Internal Medicine, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, Fukui 910-1193, Japan; Department of Aging and Dementia (DAD), University of Fukui, Fukui, Japan.

Mari Honma (M)

Department of Neurology, Masu Memorial Hospital, 100 Sumiyoshi, Nihonmatsu 964-0867, Japan.

Moeko Noguchi-Shinohara (M)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8604, Japan; Department of Preemptive Medicine for Dementia, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Ichiro Nozaki (I)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8604, Japan.

Yosikazu Nakamura (Y)

Department of Public Health, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Japan.

Tetsuyuki Kitamoto (T)

Division of CJD Science and Technology, Department of Neurological Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.

Masafumi Harada (M)

Department of Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Hidehiro Mizusawa (H)

National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira 187-8551, Japan.

Masahito Yamada (M)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8604, Japan. Electronic address: m-yamada@med.kanazawa-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH